Longitude Capital Partners III, LLC is 10% at Sierra Oncology, Inc. (SRRA). They have made 1 open-market trade across 1 company since 2022, most recently 2022-04-27.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.0M since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INZY | BUY | 2022-04-19 | 2022-04-21 | $3.69 | $5.0M | -18.0% | -14.7% | -8.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.